share_log

Matinas BioPharma | 8-K: Matinas BioPharma Reports Third Quarter 2023 Financial Results and Provides a Business Update

SEC announcement ·  Nov 8, 2023 16:06
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more